CELSUS LABORATORIES, INC. Trademark

Trademark Overview


On Thursday, June 20, 2013, a trademark application was filed for CELSUS LABORATORIES, INC. with the United States Patent and Trademark Office. The USPTO has given the CELSUS LABORATORIES, INC. trademark a serial number of 85965292. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 30, 2020. This trademark is owned by Celsus Laboratories, Inc.. The CELSUS LABORATORIES, INC. trademark is filed in the Chemical Products category with the following description:

Active pharmaceutical ingredients, namely, heparin and other glycosaminoglycans and derivatives thereof, for use in the manufacture of pharmaceutical drug products and preparations for the prevention or treatment of diseases, namely, those associated with thrombosis and hemostasis; Active pharmaceutical ingredients, namely, heparin and other glycosaminoglycans and derivatives thereof, for use in the manufacture of blood-interacting medical devices, dialyzers and stents used in the prevention and treatment of disorders, namely, those associated with thrombosis and hemostasis; Active pharmaceutical ingredients, namely, heparin and other glycosaminoglycans and derivatives thereof, for use as ligands in affinity chromatography
celsus laboratories, inc.

General Information


Serial Number85965292
Word MarkCELSUS LABORATORIES, INC.
Filing DateThursday, June 20, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 30, 2020
Registration Number4500839
Registration DateTuesday, March 25, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2014

Trademark Statements


Disclaimer with Predetermined Text"LABORATORIES, INC."
Goods and ServicesActive pharmaceutical ingredients, namely, heparin and other glycosaminoglycans and derivatives thereof, for use in the manufacture of pharmaceutical drug products and preparations for the prevention or treatment of diseases, namely, those associated with thrombosis and hemostasis; Active pharmaceutical ingredients, namely, heparin and other glycosaminoglycans and derivatives thereof, for use in the manufacture of blood-interacting medical devices, dialyzers and stents used in the prevention and treatment of disorders, namely, those associated with thrombosis and hemostasis; Active pharmaceutical ingredients, namely, heparin and other glycosaminoglycans and derivatives thereof, for use as ligands in affinity chromatography

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 30, 2020
Primary Code001
First Use Anywhere DateWednesday, March 1, 1989
First Use In Commerce DateWednesday, March 1, 1989

Trademark Owner History


Party NameCelsus Laboratories, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45241

Party NameCelsus Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45241

Party NameCelsus Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45241

Trademark Events


Event DateEvent Description
Friday, October 30, 2020CANCELLED SEC. 8 (6-YR)
Monday, March 25, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 25, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, January 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 30, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 22, 2013ASSIGNED TO LIE
Saturday, November 2, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 1, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 1, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 1, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 29, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 29, 2013NON-FINAL ACTION E-MAILED
Sunday, September 29, 2013NON-FINAL ACTION WRITTEN
Saturday, September 28, 2013ASSIGNED TO EXAMINER
Tuesday, July 2, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 24, 2013NEW APPLICATION ENTERED IN TRAM